Detailansicht

Wissensnetz

Person

Mike Sathekge

Name	Mike Sathekge
Ort	Pretoria (Wirkungsort) Staat Südafrika
Akademischer Grad bzw. Titel	Prof.
Variante	Mike M. Sathekge M.M. Sathekge
Beziehung	University of Pretoria
Weitere Angaben	Stand 2020: Leiter des Department of Nuclear Medicine, University of Pretoria, Pretoria
Datensatztyp	Person
GND-Nummer	1203400837
Datensatz-ID	1203400837
Beteiligt an alle anzeigen Nuclear Medicine Imaging of Gynecological Malignancies: The Tumor, the Tumor Microenvironment, and Beyond [18F]FDG PET and CT findings at therapy completion of pulmonary tuberculosis: comparison between HIV-positive and HIV-negative patients and impact on treatment response assessment Can current preclinical strategies for radiopharmaceutical development meet the needs of targeted alpha therapy? Guiding principles on the education and practice of theranostics Head-to-head intra-individual comparison of biodistribution and tumor uptake of 68Ga-FAPI and 18F-FDG PET/CT in cancer patients The Theranostic Optimization of PSMA-GCK01 Does Not Compromise the Imaging Characteristics of [99mTc]Tc-PSMA-GCK01 Compared to Dedicated Diagnostic [99mTc]Tc-EDDA/HYNIC-iPSMA in Prostate Cancer PSMA-based alpha therapy in prostate cancer Introducing a secondary segmentation to construct a radiomics model for pulmonary tuberculosis cavities 225Ac-PSMA-617 radioligand therapy of de novo metastatic hormone-sensitive prostate carcinoma (mHSPC): preliminary clinical findings Hematologic toxicity profile and efficacy of [225Ac]Ac-PSMA-617 α-radioligand therapy of patients with extensive skeletal metastases of castration-resistant prostate cancer Development of nuclear medicine in Africa The clinical utility of 2-deoxy-2-[18F]fluoro-d-glucose positron emission tomography in guiding myocardial revascularisation Head-to-head intra-individual comparison of biodistribution and tumor uptake of 68Ga-FAPI and 18F-FDG PET/CT in cancer patients Molecular imaging of cardiovascular inflammation and infection in people living with HIV infection A prospective intra-individual comparison of [68Ga]Ga-PSMA-11 PET/CT, [68Ga]Ga-NODAGAZOL PET/CT, and [99mTc]Tc-MDP bone scintigraphy for radionuclide imaging of prostate cancer skeletal metastases 68Ga-PSMA: a One-stop Shop in Radioactive Iodine Refractory Thyroid Cancer? Correction to: 225Ac-PSMA-617 in chemotherapy-naive patients with advanced prostate cancer: a pilot study Treatment of brain metastases of castration-resistant prostate cancer with 225Ac-PSMA-617 Radionuclide imaging of inflammation in atherosclerotic vascular disease among people living with HIV infection: current practice and future perspective 225Ac-PSMA-617 in chemotherapy-naive patients with advanced prostate cancer: a pilot study The optimal TSH level necessary for successful radioiodine ablation of differentiated thyroid carcinoma, as well as the time to reach this level, is a work in progress Molecular imaging in musculoskeletal infections with 99mTc-UBI 29-41 SPECT/CT 68Ga-PSMA-11 PET/CT in primary staging of prostate carcinoma: preliminary results on differences between black and white South-Africans

Hinweis

Die Betaversion beinhaltet noch nicht alle Funktionen und Informationen des Katalogs des DNB-Portals. Falls Sie Informationen vermissen oder ein Medium bestellen wollen, besuchen Sie bitte die entsprechende Seite im Katalog des DNB-Portals über folgenden Link:

Katalog der Deutschen Nationalbibliothek

Mike Sathekge

Nuclear Medicine Imaging of Gynecological Malignancies: The Tumor, the Tumor Microenvironment, and Beyond

[18F]FDG PET and CT findings at therapy completion of pulmonary tuberculosis: comparison between HIV-positive and HIV-negative patients and impact on treatment response assessment

Can current preclinical strategies for radiopharmaceutical development meet the needs of targeted alpha therapy?

Guiding principles on the education and practice of theranostics

Head-to-head intra-individual comparison of biodistribution and tumor uptake of 68Ga-FAPI and 18F-FDG PET/CT in cancer patients

The Theranostic Optimization of PSMA-GCK01 Does Not Compromise the Imaging Characteristics of [99mTc]Tc-PSMA-GCK01 Compared to Dedicated Diagnostic [99mTc]Tc-EDDA/HYNIC-iPSMA in Prostate Cancer

PSMA-based alpha therapy in prostate cancer

Introducing a secondary segmentation to construct a radiomics model for pulmonary tuberculosis cavities

225Ac-PSMA-617 radioligand therapy of de novo metastatic hormone-sensitive prostate carcinoma (mHSPC): preliminary clinical findings

Hematologic toxicity profile and efficacy of [225Ac]Ac-PSMA-617 α-radioligand therapy of patients with extensive skeletal metastases of castration-resistant prostate cancer

Development of nuclear medicine in Africa

The clinical utility of 2-deoxy-2-[18F]fluoro-d-glucose positron emission tomography in guiding myocardial revascularisation

Head-to-head intra-individual comparison of biodistribution and tumor uptake of 68Ga-FAPI and 18F-FDG PET/CT in cancer patients

Molecular imaging of cardiovascular inflammation and infection in people living with HIV infection

A prospective intra-individual comparison of [68Ga]Ga-PSMA-11 PET/CT, [68Ga]Ga-NODAGAZOL PET/CT, and [99mTc]Tc-MDP bone scintigraphy for radionuclide imaging of prostate cancer skeletal metastases

68Ga-PSMA: a One-stop Shop in Radioactive Iodine Refractory Thyroid Cancer?

Correction to: 225Ac-PSMA-617 in chemotherapy-naive patients with advanced prostate cancer: a pilot study

Treatment of brain metastases of castration-resistant prostate cancer with 225Ac-PSMA-617

Radionuclide imaging of inflammation in atherosclerotic vascular disease among people living with HIV infection: current practice and future perspective

225Ac-PSMA-617 in chemotherapy-naive patients with advanced prostate cancer: a pilot study

The optimal TSH level necessary for successful radioiodine ablation of differentiated thyroid carcinoma, as well as the time to reach this level, is a work in progress

Molecular imaging in musculoskeletal infections with 99mTc-UBI 29-41 SPECT/CT

68Ga-PSMA-11 PET/CT in primary staging of prostate carcinoma: preliminary results on differences between black and white South-Africans